{"disease":{"id":"alcohol-associated-liver-disease","name":"alcohol associated liver disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06472973","title":"ADDICTOlogical Intervention in LIVEr Transplantation Recipients","phase":"NA","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07149571","title":"To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06403332","title":"Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.","phase":"NA","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT07046819","title":"Tirzepatide in MetALD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","has_results":false},{"nct_id":"NCT04781322","title":"Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","has_results":false},{"nct_id":"NCT07465588","title":"Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04555434","title":"Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Chuncheon Sacred Heart Hospital","has_results":false},{"nct_id":"NCT06465186","title":"A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06113003","title":"The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":63,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT05178069","title":"LGG Supplementation in Patients With AUD and ALD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Louisville","has_results":false},{"nct_id":"NCT07093346","title":"The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT07284862","title":"A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Zhujiang Hospital","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}